DEC 15, 2018 4:18 PM PST

HIV Vaccine Successful in Non-human Primates

WRITTEN BY: Carmen Leitch

Researchers have been trying to create a vaccine for HIV, the virus that causes AIDS, for decades. Scientists at Scripps Research have reported new work in the journal Immunity that has shown that an experimental vaccine strategy they developed has been successful in a non-human primate model - rhesus macaque monkeys. The monkeys produced antibodies against a strain of HIV that is similar to one commonly infecting people, which is called a Tier 2 virus. This is also the first work to demonstrate the level of antibodies that a vaccine needs to produce in order to protect a person against HIV infection.

This image shows new HIV particles exiting an infected T-cell. / Credit: National Institutes of Health

"We found that neutralizing antibodies that have been induced by vaccination can protect animals against viruses that look a lot like real-world HIV," said Dennis Burton, Ph.D., chair of Scripps Research's Department of Immunology and Microbiology, and scientific director of the International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center and of the National Institutes of Health's Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID).

It’s still a long way from clinical trials in people, but this work shows that the strategy developed by Burton and colleagues should be pursued. The scientists aim to find the vulnerable parts of the virus and teach the human immune system to generate antibodies that will attack those parts. 

Previous work led by Scripps Research investigators pinpointed the outer envelope protein trimer of the virus as a vulnerability. Animal studies confirmed that antibodies were effective on the area. The trimer is unstable, however, and difficult to use in a vaccine. Eventually, researchers were able to create a more stable version of the trimer, called SOSIP, in 2013.

"For the first time, we had something that looked pretty much like the HIV envelope protein trimer," explained the co-first author of the new report, Matthias Pauthner, Ph.D., a research associate at Scripps Research.

The scientists designed a vaccine that contained the SOSIP trimer and went to work investigating whether animals were protected. Investigators had already learned that some monkeys had low antibody levels, or titers, after being exposed to the vaccine but in other monkeys, titers were high. In this work, they re-vaccinated six low- and six high-titer monkeys, and twelve that were unimmunized.

The re-vaccinated primates were exposed to SHIV, a simian version of HIV with an envelope trimer that matches the human one. Like circulating HIV strains that infect people, SHIV is a Tier 2 virus because it is tough to neutralize. In the high-titer animals that were re-vaccinated, however, the strategy prevented infection.

"Since HIV emerged, this is the first evidence we have of antibody-based protection from a Tier 2 virus following vaccination," said Pauthner. "One question now is how can we get such high titers into every animal?"

Titers are important to watch because protection from HIV waned as time went on, and titers fell. The researchers saw that titers had to be maintained to keep up the shield against HIV. Those neutralizing antibodies were critical to stopping the virus, unlike other parts of the immune system. Pauthner noted the significance of this finding; other labs often use immune T cells in their work instead.

The scientists want to keep titers high and improve the vaccine for human trials. "There are many immunological tricks that can be explored to make immunity last longer," said Pauthner.

Next, the investigators are going to attempt to use molecules called broadly neutralizing antibodies (bnAbs), which are effective against many different HIV strains instead of just one, like these studies. This work helps lay the foundation for those future work. "This research gives an estimate of the levels of bnAbs that we may need to induce through vaccination in order to protect against HIV globally," explained Burton.

Learn more about why it’s important to create a vaccine for HIV from the video above by Harvard University.


Sources: AAAS/Eurekalert! Via Scripps Research Institute, Immunity

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUL 27, 2020
Cell & Molecular Biology
White Blood Cells Are Essential to the Developing Brain
JUL 27, 2020
White Blood Cells Are Essential to the Developing Brain
The brain is protected by a protective shield called the blood-brain barrier, which only allows certain things to pass t ...
JUL 31, 2020
Genetics & Genomics
Researchers Create an Epigenetic Map of Development
JUL 31, 2020
Researchers Create an Epigenetic Map of Development
The protein-coding genes in the genome produce protein when they're active, or expressed. Learning how gene activity is ...
AUG 02, 2020
Cell & Molecular Biology
'Wasabi' Receptor Can Detect Many Irritants
AUG 02, 2020
'Wasabi' Receptor Can Detect Many Irritants
We're often exposed to irritants as mild as garlic or horseradish and as serious as smoke, which trigger a protective re ...
AUG 10, 2020
Cell & Molecular Biology
Lead Exposure Seems to Affect Gene Expression in Kids
AUG 10, 2020
Lead Exposure Seems to Affect Gene Expression in Kids
We have known for decades that lead harms the body. This work can help explain how that happens.
SEP 09, 2020
Cell & Molecular Biology
Why Liver Gene Therapies Have Not Worked & How to Improve Them
SEP 09, 2020
Why Liver Gene Therapies Have Not Worked & How to Improve Them
Diseases that are caused by errors in a gene might be cured if we could correct those errors, or genetic mutations.
SEP 14, 2020
Cell & Molecular Biology
Learning More About How Cells Use Phase Separation
SEP 14, 2020
Learning More About How Cells Use Phase Separation
It was once thought that cellular machines called organelles, which are structures bound by membranes, directed most of ...
Loading Comments...